| 000 | 01839 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514183550.0 | ||
| 264 | 0 | _c20050624 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0261-4189 | ||
| 024 | 7 |
_a10.1038/sj.emboj.7600136 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQian, Xiaolan | |
| 245 | 0 | 0 |
_aE-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. _h[electronic resource] |
| 260 |
_bThe EMBO journal _cApr 2004 |
||
| 300 |
_a1739-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCadherins _xgenetics |
| 650 | 0 | 4 | _aCatenins |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 |
_aCell Adhesion Molecules _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 |
_aCytoskeletal Proteins _xgenetics |
| 650 | 0 | 4 |
_aDNA _xbiosynthesis |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aEpithelial Cells _xcytology |
| 650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aPhosphoproteins _xgenetics |
| 650 | 0 | 4 | _aProtein Transport |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xmetabolism |
| 650 | 0 | 4 |
_aTrans-Activators _xgenetics |
| 650 | 0 | 4 |
_aTransformation, Genetic _xgenetics |
| 650 | 0 | 4 | _abeta Catenin |
| 650 | 0 | 4 | _aDelta Catenin |
| 700 | 1 | _aKarpova, Tatiana | |
| 700 | 1 | _aSheppard, Allan M | |
| 700 | 1 | _aMcNally, James | |
| 700 | 1 | _aLowy, Douglas R | |
| 773 | 0 |
_tThe EMBO journal _gvol. 23 _gno. 8 _gp. 1739-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.emboj.7600136 _zAvailable from publisher's website |
| 999 |
_c14773535 _d14773535 |
||